SGLT2 inhibitors: the story continues to unfold

被引：3
作者：
Pina, Ileana L. [1 ]
机构：
[1] Cent Michigan Univ, Coll Med, 2627 Fairmount Blvd, Midlands, MI 48640 USA
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷 / 48期
关键词：
HEART-FAILURE; SERUM POTASSIUM; OUTCOMES;
D O I：
10.1093/eurheartj/ehab561
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4902 / 4904
页数：3
相关论文
共 50 条
  • [41] The Intersection of SGLT2 Inhibitors, Cognitive Impairment, and CKD
    Noel, J. Ariana
    Hougen, Ingrid
    Sood, Manish M.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [42] SGLT2 inhibitors to prevent diabetic kidney disease
    Fioretto, Paola
    Vettor, Roberto
    Pontremoli, Roberto
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (01) : 4 - 5
  • [43] Extrarenal Benefits of SGLT2 Inhibitors in the Treatment of Cardiomyopathies
    Yerra, Veera Ganesh
    Connelly, Kim A.
    PHYSIOLOGY, 2024, 39 (06) : 412 - 434
  • [44] SGLT2 inhibitors and heart failure - clinical implications
    Raz, Itamar
    Cahn, Avivit
    NATURE REVIEWS CARDIOLOGY, 2016, 13 (04) : 185 - 186
  • [45] SGLT2 inhibitors for primary prevention of cardiovascular events
    Raz, Itamar
    Cernea, Simona
    Cahn, Avivit
    JOURNAL OF DIABETES, 2020, 12 (01) : 5 - 7
  • [46] Possible mechanisms of cardiovascular benefits of SGLT2 inhibitors
    Verges, B.
    ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS, 2019, 11 : S18 - S22
  • [47] Cardiac effects of SGLT2 inhibitors: the sodium hypothesis
    Bertero, Edoardo
    Roma, Leticia Prates
    Ameri, Pietro
    Maack, Christoph
    CARDIOVASCULAR RESEARCH, 2018, 114 (01) : 12 - 18
  • [48] An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
    Salvatore, Teresa
    Galiero, Raffaele
    Caturano, Alfredo
    Rinaldi, Luca
    Di Martino, Anna
    Albanese, Gaetana
    Di Salvo, Jessica
    Epifani, Raffaella
    Marfella, Raffaele
    Docimo, Giovanni
    Lettieri, Miriam
    Sardu, Celestino
    Sasso, Ferdinando Carlo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [49] SGLT2 inhibitors and finerenone: one or the other or both?
    Neuen, Brendon L.
    Jardine, Meg J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (07) : 1209 - 1211
  • [50] SCORED and SOLOIST: the next scores for SGLT2 inhibitors
    Bauersachs, Johann
    CARDIOVASCULAR RESEARCH, 2021, 117 (04) : E49 - E51
12345